Diffuse alveolar hemorrhage and recombinant factor VIIa treatment in pediatric patients

Diffuse alveolar hemorrhage (DAH) is a life-threatening pulmonary complication in patients with hematologic malignancies or autoimmune disorders. The current treatment options, which include corticosteroids, transfusions, extracorporeal membrane oxygenation (ECMO), and immunosuppressants, have been...

Descripción completa

Detalles Bibliográficos
Autor principal: Park, Jeong A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Pediatric Society 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865620/
https://www.ncbi.nlm.nih.gov/pubmed/27186216
http://dx.doi.org/10.3345/kjp.2016.59.3.105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865620/
https://www.ncbi.nlm.nih.gov/pubmed/27186216
http://dx.doi.org/10.3345/kjp.2016.59.3.105

Ejemplares similares